221 related articles for article (PubMed ID: 24637461)
1. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.
Reaves DK; Fagan-Solis KD; Dunphy K; Oliver SD; Scott DW; Fleming JM
PLoS One; 2014; 9(3):e91747. PubMed ID: 24637461
[TBL] [Abstract][Full Text] [Related]
2. Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.
Fagan-Solis KD; Reaves DK; Rangel MC; Popoff MR; Stiles BG; Fleming JM
Mol Cancer; 2014 Jul; 13():163. PubMed ID: 24990559
[TBL] [Abstract][Full Text] [Related]
3. The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells.
Shimada H; Satohisa S; Kohno T; Takahashi S; Hatakeyama T; Konno T; Tsujiwaki M; Saito T; Kojima T
Oncotarget; 2016 May; 7(19):27735-52. PubMed ID: 27036040
[TBL] [Abstract][Full Text] [Related]
4. The Behavior and Role of Lipolysis-stimulated Lipoprotein Receptor, a Component of Tricellular Tight Junctions, in Head and Neck Squamous Cell Carcinomas.
Takano K; Kakuki T; Obata K; Nomura K; Miyata R; Kondo A; Kurose M; Kakiuchi A; Kaneko Y; Kohno T; Himi T; Kojima T
Anticancer Res; 2016 Nov; 36(11):5895-5904. PubMed ID: 27793914
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Prat A; Parker JS; Karginova O; Fan C; Livasy C; Herschkowitz JI; He X; Perou CM
Breast Cancer Res; 2010; 12(5):R68. PubMed ID: 20813035
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.
Reaves DK; Hoadley KA; Fagan-Solis KD; Jima DD; Bereman M; Thorpe L; Hicks J; McDonald D; Troester MA; Perou CM; Fleming JM
Mol Cancer Res; 2017 Feb; 15(2):165-178. PubMed ID: 27856957
[TBL] [Abstract][Full Text] [Related]
7. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.
Nagase Y; Hiramatsu K; Funauchi M; Shiomi M; Masuda T; Kakuda M; Nakagawa S; Miyoshi A; Matsuzaki S; Kobayashi E; Kimura T; Serada S; Ueda Y; Naka T; Kimura T
BMC Cancer; 2022 Jun; 22(1):679. PubMed ID: 35729527
[TBL] [Abstract][Full Text] [Related]
8. Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer.
Shimada H; Abe S; Kohno T; Satohisa S; Konno T; Takahashi S; Hatakeyama T; Arimoto C; Kakuki T; Kaneko Y; Takano KI; Saito T; Kojima T
Sci Rep; 2017 Jan; 7():37049. PubMed ID: 28071680
[TBL] [Abstract][Full Text] [Related]
9. ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer.
Konno T; Kohno T; Okada T; Shimada H; Satohisa S; Kikuchi S; Saito T; Kojima T
Histochem Cell Biol; 2020 Aug; 154(2):197-213. PubMed ID: 32266459
[TBL] [Abstract][Full Text] [Related]
10. Tricellular tight junction protein LSR/angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line.
Kyuno T; Kyuno D; Kohno T; Konno T; Kikuchi S; Arimoto C; Yamaguchi H; Imamura M; Kimura Y; Kondoh M; Takemasa I; Kojima T
Histochem Cell Biol; 2020 Jan; 153(1):5-16. PubMed ID: 31650247
[TBL] [Abstract][Full Text] [Related]
11. Localization of Tricellular Tight Junction Molecule LSR at Midbody and Centrosome During Cytokinesis in Human Epithelial Cells.
Konno T; Kohno T; Kikuchi S; Shimada H; Satohisa S; Takano K; Saito T; Kojima T
J Histochem Cytochem; 2020 Jan; 68(1):59-72. PubMed ID: 31662022
[TBL] [Abstract][Full Text] [Related]
12. HMGB1-downregulated angulin-1/LSR induces epithelial barrier disruption via claudin-2 and cellular metabolism via AMPK in airway epithelial Calu-3 cells.
Kodera Y; Chiba H; Konno T; Kohno T; Takahashi H; Kojima T
Biochem Biophys Res Commun; 2020 Jun; 527(2):553-560. PubMed ID: 32423802
[TBL] [Abstract][Full Text] [Related]
13. Tricellular tight junction-associated angulins in the gill epithelium of rainbow trout.
Kolosov D; Kelly SP
Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R312-R322. PubMed ID: 29631364
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Tricellular Tight Junction Protein Angulin-1/Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Endometriosis and Endometrioid-Endometrial Carcinoma.
Shimada H; Kohno T; Konno T; Okada T; Saito K; Shindo Y; Kikuchi S; Tsujiwaki M; Ogawa M; Matsuura M; Saito T; Kojima T
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944960
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.
Arai W; Konno T; Kohno T; Kodera Y; Tsujiwaki M; Shindo Y; Chiba H; Miyajima M; Sakuma Y; Watanabe A; Kojima T
Oncotarget; 2023 Mar; 14():261-275. PubMed ID: 36961882
[TBL] [Abstract][Full Text] [Related]
16. Angulin-1 (LSR) Affects Paracellular Water Transport, However Only in Tight Epithelial Cells.
Ayala-Torres C; Krug SM; Rosenthal R; Fromm M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360593
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Funauchi M; Serada S; Hiramatsu K; Funajima E; Kanda M; Nagase Y; Nakagawa S; Ohkawara T; Fujimoto M; Suzuki Y; Ueda Y; Kimura T; Naka T
Int J Cancer; 2024 Feb; 154(3):425-433. PubMed ID: 37728485
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.
Gerhard R; Ricardo S; Albergaria A; Gomes M; Silva AR; Logullo ÂF; Cameselle-Teijeiro JF; Paredes J; Schmitt F
Breast; 2012 Jun; 21(3):354-60. PubMed ID: 22464177
[TBL] [Abstract][Full Text] [Related]
19. Effects of Lipolysis-Stimulated Lipoprotein Receptor on Tight Junctions of Pancreatic Ductal Epithelial Cells in Hypertriglyceridemic Acute Pancreatitis.
Wang J; Qin M; Wu Q; Yang H; Wei B; Xie J; Qin Y; Liang Z; Huang J
Biomed Res Int; 2022; 2022():4234186. PubMed ID: 35463981
[TBL] [Abstract][Full Text] [Related]
20. Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer.
Kanda M; Serada S; Hiramatsu K; Funauchi M; Obata K; Nakagawa S; Ohkawara T; Murata O; Fujimoto M; Chiwaki F; Sasaki H; Ueda Y; Kimura T; Naka T
Neoplasia; 2023 Jan; 35():100853. PubMed ID: 36413881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
